Christian Dingler is an associate director within the Life Sciences Governance, Risk Management and Compliance practice. He supports life science companies implement, improve, and remediate compliance programs including those under government oversight (e.g., CIA, DPA, etc.).
Christian has implemented compliance programs at pharmaceutical, medical device, and diagnostic companies in the US and internationally. He has served in interim compliance leadership roles as head of compliance, monitoring and transparency. Christian emphasizes a risk-based approach to compliance and has expertise conducting healthcare compliance and enterprise-wide risk assessments, along with creating and operationalizing risk mitigation plans throughout large, complex organizations.
Christian is a frequent author and speaker on the principles of healthcare compliance including to Boards of Directors, executive teams and industry groups such as the Pharmaceutical Compliance Congress, Pharmaceutical Compliance Forum, and Healthcare Information and Management Systems Society (HIMSS) Legal Task Force.
Selected expertise includes: developing compliance written standards (codes, policies, procedures, etc.); implementing risk assessments and risk mitigation plans; developing auditing and monitoring plans and conducting live and desktop compliance monitoring; leading Independent Review Organization (IRO) teams and supporting clients under Corporate Integrity Agreements (CIA); conducting compliance program assessments; and conducting targeted reviews of high-risk activities (e.g., patient support programs, transparency, HCP contracting, etc.).
M.B.A., Virginia Commonwealth University School of Business B.A., Finance and Accounting, College of William & Mary